Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old

NCT00224484 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

5960

Enrollment

INDUSTRY

Sponsor class

Conditions

Herpes Simplex

Interventions

BIOLOGICAL: GSK208141
BIOLOGICAL: Havrix (investigational formulation)
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline